BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Contract Manufacturing

Catalent builds $20M expansion for German clinical supply facility

Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has begun construction of ...

April 06, 2023 | News

WuXi STA Adds New Peptide Manufacturing Capacity and Large-Scale Continuous Purification System

WuXi STA, a global Contract Research, Development, and Manufacturing Organization (CRDMO), announces that it has added two 2,000 L reactors and a lar...

April 06, 2023 | News

Bridgewest Group launches NovaCina, new sterile injectable CDMO

The newly acquired facility and team is in Bentley, a suburb of Perth in Western Australia. It will operate as a Contract Development and Ma...

April 05, 2023 | News

Cambrex Opens New Stability Storage Facility in Belgium

Strategically located in the Liège region and approximately 90 kilometers from Brussels, the new state-of-the-art temperature-controlled and mo...

April 04, 2023 | News

Evonik breaks ground on $220 million Lipid Innovation Center

Facility to secure global supply of functional excipients for RNA medicines Cooperative agreement with U.S. Government to advance U.S. biopharma industr...

March 30, 2023 | News

Vetter Performs Extraordinarily with Six Wins in the 12th Annual CDMO Leadership Awards

▪ Vetter celebrates its second consecutive year earning this award in six categories with three additional honors in the CDMO Leadership Awards&nbs...

March 28, 2023 | News

WuXi Biologics Reports Remarkable 2022 Annual Results

2022 Financial Highlights Revenue: The Group's revenue increased to RMB15,268.7 million with an increase of 48.4% y-o-y. The increase was...

March 23, 2023 | News

Remedium and Exothera partner on scale-up and demonstration runs for AAV2-FGF18

Remedium’s lead candidate is the only disease modifying gene therapy based on the clinically proven regenerative mechanism of FGF18. OA is the larges...

March 22, 2023 | News

3SBio Reports 7.5% YoY Revenue Growth and 25.2% Jump in Profit for 2022

New drugs started to embrace a commercialization wave, and license-out and license-in partnerships geared up. Revenue in 2022 increased by 7.5% year on yea...

March 22, 2023 | News

Hovione and Ripple Partner to Expand Epidel® Platform Beyond Ophthalmology.

The core feature of Ripple's Epidel® technology is the ability to deliver sustained-release pharmaceuticals with surface erosion release kinetics witho...

March 21, 2023 | News

Samsung Biologics to build Plant 5 for Bio Campus II expansion.

The company plans to begin construction in the first half of 2023 and commence operations in 2025 As part of Samsung Biologics' second Bio Campus, ...

March 17, 2023 | News

Vetter strengthens worldwide commitment to sustainable business practices

Globally, Vetter is one of over 300 companies in the pharma and biotech industrythat have signed the UN Global Compact Membership drives expansion of ec...

March 08, 2023 | News

GenScript ProBio Congratulates Eutilex's IND Clearance from MFDS

GenScript ProBio extends congratulations on this. 2 years ago, GenScript ProBio and Eutilex announced that the parties entered into strategic collaboration...

March 07, 2023 | News

ExoCoBio Obtains GMP Licenses for Exosome Biopharmaceuticals and HA Dermal Fillers

ExoGMP™ is the world's largest exosome manufacturing facility in Osong, South Korea. Cellosome™ HA fillers are expected to be approved ...

March 02, 2023 | News

Stay Connected